<![CDATA[04 National Adoption of Ultra-Hypofractionated (5-Fraction) External Beam Radiation Therapy in the United States, 2020–2023: An NCDB Analysis]]>

Summary

An NCDB analysis of 536,783 breast radiation courses from 2020-2023 shows that 5-fraction ultra-hypofractionated external beam radiation therapy adoption increased from 4.3% to 17.4%, with average adoption of 10.7% across the period.